Half of New Drugs Launched Lack Added Therapeutic Value: In a startling revelation that could have significant implications for the pharmaceutical industry, researchers have found that half of the new drugs launched in the American and European markets between 2011 and 2020 do not offer added therapeutic value. The study evaluated these drugs based on their assessment by the High Authority of Health and its … Continue reading Half of New Drugs Launched Lack Added Therapeutic Value, Researchers Find